跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 66,575 条关于
“T-cell–engaging bispecific antibodies”
全部
66,575
临床试验
45,295
药物
6,627
机构
240
资讯
14,413
6个月前
Context Therapeutics Advances T-Cell Engager Pipeline with Three Bispecific Antibodies in Clinical Development
2个月前
Second Primary Malignancies Emerge as Clinically Relevant Complication of T-Cell–Engaging Bispecific Antibody Therapy
16天前
Treeline and Roche Collaborate on Phase 1 Trial of BCL6 Degrader TLN-121 Combined with CD20×CD3 Bispecifics in B-Cell Lymphomas
去年
Context Therapeutics Initiates Phase 1 Trial of CTIM-76 for CLDN6-Positive Cancers
11个月前
Context Therapeutics Advances Two Bispecific T Cell Engagers with Promising Early Clinical and Preclinical Data at SITC 2025
5个月前
Context Therapeutics Receives FDA Fast Track Designation for CTIM-76 in Platinum-Resistant Ovarian Cancer
2年前
Bispecific Antibodies and CAR T-cell Therapies Revolutionize Treatment of Relapsed/Refractory Lymphomas
去年
Sequencing Bispecific Antibodies and CAR T-Cell Therapy in Multiple Myeloma Treatment
4年前
CAR-T Therapy Demonstrates Superior Efficacy Over Bispecific Antibodies in Relapsed/Refractory Follicular Lymphoma
去年
Novel Evobody Bispecific Antibodies Show Promise in Ovarian Cancer by Targeting Vγ9Vδ2 T Cells
第 1 页,共 1442 页
上一页
下一页